title: Topical linezolid for refractory bilateral Mycobacterium chelonae post-laser-assisted in situ keratomileusis keratitis.
authors.forename: Rosa
authors.initials: R
authors.lastname: Dolz-Marco
authors.forename: Patricia
authors.initials: P
authors.lastname: Udaondo
authors.forename: Roberto
authors.initials: R
authors.lastname: Gallego-Pinazo
authors.forename: J Maria
authors.initials: JM
authors.lastname: Millán
authors.forename: Manuel
authors.initials: M
authors.lastname: Díaz-Llopis
mesh_terms: D000081:Acetamides / Q000008:administration & dosage*; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage; D003315:Cornea / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D024881:Drug Resistance, Bacterial; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D005500:Follow-Up Studies; D006801:Humans; D007634:Keratitis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D020731:Keratomileusis, Laser In Situ / Q000009:adverse effects*; D000069349:Linezolid; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D016926:Mycobacterium chelonae / Q000302:isolation & purification*; D009216:Myopia / Q000601:surgery; D023303:Oxazolidinones / Q000008:administration & dosage*; D012338:RNA, Ribosomal, 23S; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D012338:RNA, Ribosomal, 23S; D000069349:Linezolid